Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment

被引:3
|
作者
Sherri, Alaa [1 ]
Mortada, Mohamad Mahdi [2 ]
Makowska, Joanna [1 ]
Lewandowska-Polak, Anna [1 ]
机构
[1] Med Univ Lodz, Dept Rheumatol, Lodz, Poland
[2] Med Univ Lodz, Dept Immunol & Allergy, Lodz, Poland
关键词
Primary angiitis of the central nervous system (PACNS); ANCA-associated vasculitis (AAV) with central nervous system involvement; Vasculitis of the central nervous system (CNS); Diagnostic workup and treatment; CENTRAL-NERVOUS-SYSTEM; INVOLVEMENT; GRANULOMATOSIS; POLYANGIITIS; MANIFESTATIONS; DIAGNOSIS; COHORT; MRI; RITUXIMAB; PATTERNS;
D O I
10.1007/s00296-023-05461-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculitis of the central nervous system can be a localized process, such as primary angiitis of the central nervous system (PACNS), or systemic vasculitis, such as ANCA-associated vasculitis (AAV). Since both conditions share neurological manifestations, the following review will discuss the neurological aspects of both. This review aims to provide a comprehensive comparison of the pathogenesis, clinical manifestation and assessment, diagnostic workup, and treatment protocol for both PACNS and AAV with central nervous system involvement. To provide a comprehensive comparison and update, a literature review was conducted using PubMed and Ovid databases (Embase and Medline). Then, the references were retrieved, screened, and selected according to the inclusion and exclusion criteria. PACNS and AAV share similarities in clinical presentation and neurological symptoms, especially in terms of headache, focal deficits, and cognitive impairment. Additionally, both conditions may exhibit similarities in laboratory and radiological findings, making brain biopsy the gold standard for differentiation between the two conditions. Moreover, the treatment protocols for PACNS and AAV are nearly identical. Comparing PACNS and AAV with CNS involvement highlights the similarities in clinical presentation, radiological findings, and treatment protocols between the two conditions. Further research should focus on establishing a practical diagnostic protocol.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 50 条
  • [21] The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis
    Okada, Masahiro
    Suemori, Koichiro
    Takagi, Daiki
    Teraoka, Masato
    Yamada, Hiroyuki
    Ishizaki, Jun
    Matsumoto, Takuya
    Hasegawa, Hitoshi
    Hato, Naohito
    AURIS NASUS LARYNX, 2019, 46 (01) : 38 - 42
  • [22] Advances in Pathogenesis and Treatment of ANCA-associated Vasculitis
    Kallenberg, Cees G. M.
    DISCOVERY MEDICINE, 2014, 18 (99) : 195 - 201
  • [23] Current treatment approach to ANCA-associated vasculitis
    Yazici, Yusuf
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (01) : 35 - 39
  • [24] Treatment of ANCA-Associated Vasculitis, Where to Go?
    Cees G. M. Kallenberg
    Clinical Reviews in Allergy & Immunology, 2012, 43 : 242 - 248
  • [25] Treatment of Severe and/or Refractory ANCA-Associated Vasculitis
    Loïc Guillevin
    Current Rheumatology Reports, 2014, 16
  • [26] Treatment of Severe and/or Refractory ANCA-Associated Vasculitis
    Guillevin, Loic
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (08)
  • [27] Treatment of ANCA-Associated Vasculitis, Where to Go?
    Kallenberg, Cees G. M.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 43 (03) : 242 - 248
  • [28] Avacopan for the Treatment of ANCA-Associated Vasculitis Reply
    Jayne, David R. W.
    Merkel, Peter A.
    Bekker, Pirow
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21)
  • [29] The role of biologics in treatment of ANCA-associated vasculitis
    Dharmapalaiah, Chethana
    Watts, Richard A.
    MODERN RHEUMATOLOGY, 2012, 22 (03) : CP10 - 326
  • [30] Renal Involvement in ANCA-associated vasculitis
    Kronbichler, Andreas
    Windpessl, Martin
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (02) : 141 - 149